Earnings History Data for Quoin Pharmaceuticals, Ltd. (QNRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare and orphan diseases. Quoin Pharmaceuticals, formerly known as Cellect Biotechnology Ltd., is based in Tel Aviv.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-03-2024 | AH | QNRX | Quoin Pharmaceuticals, Ltd. | 1.13 | -2.08 | -2.37 | -4.92 | Quoin Pharmaceuticals GAAP EPS of -$2.08 [3/13/2024 4:21 PM] |
1.08 | -0.08 (-6.90%) |
1.13 | -0.03 (-2.59%) |
1.04 - 12.00 | 288,751 | 3,510,000 | 22,702 | ||
| 08-11-2023 | AH | QNRX | Quoin Pharmaceuticals, Ltd. | 4.46 | -1.95 | -2.40 | -11.28 | Quoin Pharmaceuticals GAAP EPS of -$7.61 misses by $4.89 [11/9/2023 10:59 AM] |
4.06 | -0.37 (-8.26%) |
4.84 | 0.37 (8.28%) |
3.66 - 33.84 | 17,141 | 10,000 | 562 | ||
| 02-08-2023 | AH | QNRX | Quoin Pharmaceuticals, Ltd. | 7.77 | -2.13 | 0.00 | -38.90 | Quoin Pharmaceuticals GAAP EPS of -$2.13 [8/2/2023 5:42 PM] |
7.43 | 0.40 (5.69%) |
7.22 | 0.19 (2.70%) |
5.04 - 337.32 | 19,278 | 770,000 | 3,385 | ||
| 08-05-2023 | AH | After the close (May 8) |
QNRX | Quoin Pharmaceuticals, Ltd. | 5.65 | -0.34 | -0.26 | -2.50 | Quoin Pharmaceuticals GAAP EPS of -$0.34 misses by $0.06 [5/8/2023 5:04 PM] |
0.4898 | -0.08 (-13.83%) |
0.54 | -0.03 (-4.82%) |
0.43 - 28.11 | 523,922 | 310,000 | 72,058 | |
| 08-03-2023 | AH | After the close (Mar 8) |
QNRX | Quoin Pharmaceuticals, Ltd. | 3.00 | -0.41 | 0.00 | 0.00 | Quoin Pharmaceuticals GAAP EPS of -$0.41 beats by $0.19 [3/8/2023 5:19 PM] |
0.5399 | -0.04 (-6.10%) |
0.63 | 0.06 (9.57%) |
0.43 - 28.11 | 529,354 | 940,000 | 268,464 | |
| 10-11-2022 | PM | 7:00 AM ET (Nov 10) |
QNRX | Quoin Pharmaceuticals, Ltd. | 8.05 | -0.94 | -2.90 | 0.00 | Quoin Pharmaceuticals Loss per ADS of -$0.94 beats by $0.41 [11/10/2022 10:00 AM] |
1.98 | 0.34 (20.73%) |
1.97 | 0.33 (20.12%) |
1.57 - 94.00 | 472,150 | 80,000 | 49,987 | |
| 18-08-2022 | PM | 0:00 AM ET (Aug 18) |
QNRX | Quoin Pharmaceuticals, Ltd. | 4.21 | -3.24 | 0.00 | -21.50 | Quoin Pharmaceuticals GAAP EPS of -$3.24 [8/18/2022 7:08 AM] |
4.86 | -0.62 (-11.31%) |
4.83 | -0.65 (-11.86%) |
3.58 - 444.00 | 2,161,906 | 6,070,000 | 369,792 | |